Browse the evidence

Blood [lactate] after FAT-ADAPT declined from 3.7 ± 1.2 mM on d-2 to 2.4 ± 0.5 mM on d-5.

A high-fat diet may lead to lower lactate accumulation during intense exercise.

The pattern of protein ingestion altered blood amino acid (AA) and insulin profiles.

Different protein ingestion patterns may optimize hormonal responses post-exercise.

There were no differences in muscle protein synthesis rates between fast and slow protein ingestion patterns.

Both fast and slow protein ingestion can be effective for muscle synthesis, with no significant difference.

The primary endpoint of the study is the difference in HbA1c levels between TRE and CP at 4 months.

Monitoring HbA1c levels will be crucial for assessing the effectiveness of TRE compared to CP.

Secondary outcomes include changes in fasting glucose, fasting insulin, HOMA-IR, and nocturnal glucose.

These secondary outcomes will provide additional insights into the metabolic effects of TRE.

Both healthy low fat (HLF) and healthy low carbohydrate (HLC) diets improved indices of insulin sensitivity after 12 months.

Both diets can be recommended for improving insulin sensitivity in overweight adults.

Ingestion of a high-fat meal increased subsequent fat availability and utilization during intense exercise compared to carbohydrate feedings.

Practitioners may consider high-fat meals to enhance fat utilization during intense exercise.

Fat feeding elevated plasma free fatty acids (FFA) and lowered respiratory exchange ratio (RER) during steady-state exercise.

High-fat meals may enhance fat metabolism during exercise.

Vegan dietary patterns can be healthy if followed very carefully with regard for potential nutritional deficiencies.

Practitioners should ensure that patients on vegan diets are aware of and manage potential nutritional deficiencies.

The likely beneficial effects of vegan dietary patterns on risk of cardiometabolic diseases and cancers are counterbalanced by the potential of such diets to be deficient in several important micronutrients.

Patients should be informed about both the benefits and potential nutritional risks of vegan diets.

Obesity can lead to skin diseases such as psoriasis and hidradenitis suppurativa.

Practitioners should be aware of the dermatological implications of obesity.

Higher intake of white rice (≥450g/d compared with <150g/d) is associated with an increased risk of diabetes (HR: 1.20; 95% CI: 1.03-1.41, p for trend=0.003).

Practitioners should consider the potential diabetes risk associated with high white rice consumption in dietary recommendations.

The highest risk of diabetes associated with white rice intake was observed in South Asia (HR: 1.65; 95% CI: 1.17-2.34, p for trend=0.02).

In South Asia, high white rice consumption may pose a greater diabetes risk, warranting tailored dietary advice.

Intragastric balloons (IGBs) may improve steatosis and fibrosis in nonalcoholic fatty liver disease and improve quality of life and mental health in the short term.

Practitioners may consider IGBs as a short-term intervention for patients with nonalcoholic fatty liver disease.

Endoscopic sleeve gastroplasty (ESG) may be more effective and durable than intragastric balloons (IGBs) and result in fewer adverse events compared to bariatric surgery.

Practitioners may consider ESG as a preferable option over IGBs and traditional bariatric surgery.

Obesity initiates the development of insulin resistance through increased adipose tissue size, inflammation, and ectopic fat deposition.

Understanding the role of obesity in insulin resistance can guide interventions.

Inflammation and fat accumulation are key drivers for losing insulin sensitivity.

Addressing inflammation and fat accumulation may improve insulin sensitivity.

Abdominoplasty following GLP-1 RA-induced massive weight loss shows a trend toward a lower overall complication rate (20% vs 40%) compared to postbariatric surgery.

Practitioners may consider GLP-1 RA therapy as a safer option for patients seeking abdominoplasty after significant weight loss.

Patients taking GLP-1 RAs had superior nutritional status compared to postbariatric patients, indicated by higher albumin and prealbumin levels.

Improved nutritional status in GLP-1 RA patients may enhance surgical outcomes and recovery.

Leptin levels significantly decline following semaglutide treatment, particularly in the obesity group (-5.10 ng/mL).

Semaglutide may help lower leptin levels, which could be beneficial for weight management in diabetic patients.

Adiponectin levels increase significantly post-semaglutide add-on therapy, with the greatest increase in the obesity group (+3.70 μg/mL).

Increased adiponectin levels with semaglutide may enhance metabolic health in diabetic patients.

Long-term mortality was significantly lower in the GLP-1 group (odds ratio 0.58, 95% CI 0.36-0.94).

GLP-1 receptor agonists may improve long-term survival in patients undergoing endovascular treatment for aneurysms.

Obesity is associated with menstrual irregularities, poorer reproductive and obstetric outcomes, and an increased risk of endometrial cancer.

Clinicians should be aware of the reproductive health risks associated with obesity in women.

Both doses of tirzepatide (10 mg and 15 mg) showed significantly greater reductions in predicted diabetes risk compared to placebo.

Practitioners may consider the effectiveness of tirzepatide over placebo in reducing diabetes risk.